COULTER® ACT DIFF 12? ANALYZER
Report
- Report Number
- 1061932-2013-00980
- Event Type
- Malfunction
- Date Received
- May 29, 2013
- Date of Event
- April 29, 2013
- Report Date
- April 29, 2013
- Manufacturer
- BECKMAN COULTER
- Product Code
- GKZ
- PMA / PMN Number
- K973634
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MI, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
THE FIELD SERVICE ENGINEER (FSE) REPLACED THE PINCH TUBING AT PINCH VALVE VL8 TO CORRECT THE FLUID LEAKING ISSUE. THE FSE PERFORMED A VERIFICATION INSPECTION REPORT (VIP) ON THE INSTRUMENT. THE FSE NOTICED THE DILUENT AND SAMPLE SYRINGE WERE LEAKING AND REPLACED THE DILUENT AND SYRINGE. THE FSE ALSO NOTICED THE PROBE WIPE WAS CORRODED AND REPLACED THE PROBE WIPE. AFTER COMPLETING VIP, THE FSE DISCOVERED PINCH VALVE LV15 WAS NO LONGER FUNCTIONING AND REPLACED THE PINCH VALVE. SERVICE ACTIVITY PERFORMED WAS VERIFIED TO MEET THE SPECIFIED REQUIREMENTS PER ESTABLISHED PROCEDURES. THE INSTRUMENT CONFORMED TO THE MANUFACTURER'S PUBLISHED SPECIFICATIONS AND WAS RETURNED TO NORMAL OPERATION. PROBE WIPE (B)(4).
THE CUSTOMER REPORTED APPROXIMATELY TEN TO TWENTY MILLILITERS OF FLUID LEAKED OUTSIDE THE INSTRUMENT AND ONTO THE COUNTER FROM THE COULTER ACT DIFF 12¿ ANALYZER DURING SYSTEM STARTUP. THE OPERATOR WAS WEARING PROTECTIVE GLOVES AT THE TIME OF THE EVENT AND DID NOT HAVE DIRECT CONTACT WITH THE FLUID. THERE WAS NO OPERATOR INJURY OR ADVERSE EFFECT ASSOCIATED WITH THIS EVENT. PATIENT RESULTS WERE NOT IMPACTED, AND THERE WAS NO PATIENT CONSEQUENCE ASSOCIATED WITH THIS EVENT. THE FACILITY HAS AN EXPOSURE CONTROL OR RISK MANAGEMENT PLAN IN PLACE. A BECKMAN COULTER FIELD SERVICE ENGINEER (FSE) WAS DISPATCHED TO ASSESS THE INSTRUMENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 235558 | COULTER® ACT DIFF 12? ANALYZER | COUNTER, DIFFERENTIAL CELL | GKZ | BECKMAN COULTER | NA | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |